A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2011
11/23/2011	CN102250346A Biodegrable cationic polymemers
11/23/2011	CN102250239A Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof
11/23/2011	CN102250234A Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof
11/23/2011	CN102250231A Chonorchis sinensis specific PPMP antigens and application thereof
11/23/2011	CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same
11/23/2011	CN102247606A DNA (deoxyribonucleic acid) level-based highly pathogenic blue-eared pig disease JEV (Japanese encephalitis virus) replicon vaccine and application thereof
11/23/2011	CN102247605A Antiviral effect of novel pathogen recognition molecule
11/23/2011	CN102247592A Novel application of ubiquitin-like modified protein in resisting virus
11/23/2011	CN101680002B A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
11/23/2011	CN101624580B Recombinant baculovirus expressing manually modified and synthesized influenza A H1N1 virus HA-NA-M1 gene
11/22/2011	US8063195 Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
11/22/2011	US8063183 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders
11/22/2011	US8063022 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
11/22/2011	US8062669 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof
11/22/2011	US8062634 Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor
11/22/2011	CA2486007C Delivery of nucleic acid-like compounds
11/22/2011	CA2456025C An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
11/22/2011	CA2416631C Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2344740C Mutant cholera holotoxin as an adjuvant
11/22/2011	CA2257826C Helicobacter pylori adhesin binding group antigen
11/17/2011	WO2011143660A2 Compositions and methods for treating leukemia
11/17/2011	WO2011143640A2 Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
11/17/2011	WO2011143609A1 Formulations of diluted genetic material and methods for making same
11/17/2011	WO2011143557A2 Humanized ttc and methods of use thereof
11/17/2011	WO2011143511A2 Methods for producing enteroendocrine cells that make and secrete insulin
11/17/2011	WO2011143323A2 Programmable self-assembled nanostructures based on sidechain-modified pna for the multivalent display of ligands
11/17/2011	WO2011143317A2 Methods for the regulation of cellular metabolism through the modulation of sirt3 activity
11/17/2011	WO2011143230A1 Methods and compositions for delivery of active agents
11/17/2011	WO2011142798A2 Methods of preparing targeted aptamer prodrugs
11/17/2011	WO2011142514A1 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease
11/17/2011	WO2011142460A1 Method for detecting schizophrenia
11/17/2011	WO2011141797A2 Isolation and use of a new type of glial cell with neurotoxic potential
11/17/2011	WO2011141705A1 Novel cationic lipids and methods of use thereof
11/17/2011	WO2011141704A1 Novel cyclic cationic lipids and methods of use
11/17/2011	WO2011140638A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	WO2011087804A3 Peptide- polynucleotide compositions for transfecting a cell with dna and for treating a neurodegenerative disease
11/17/2011	WO2011085276A3 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer
11/17/2011	WO2011082409A3 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/17/2011	WO2011079263A3 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
11/17/2011	WO2011079261A3 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
11/17/2011	WO2011057243A3 Administration of plant expressed oral tolerance agents
11/17/2011	WO2010109053A8 Methods and compositions for the treatment of cirrhosis and liver fibrosis
11/17/2011	US20110281937 Methods and compositions for treating neuropathic and neurodegenerative conditions
11/17/2011	US20110281931 Rna sequence-specific mediators of rna interference
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281786 Stem cell expansion enhancing factor and method of use
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280944 Fibrous microcapsules and methods of assembly and use thereof
11/17/2011	US20110280935 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/17/2011	US20110280885 Cancer immunotherapy
11/17/2011	US20110280856 Treatment of alpha-galactosidase a deficiency
11/17/2011	US20110280844 Hepatocyte production by forward programming
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	CA2833415A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	CA2799470A1 Humanized ttc and methods of use thereof
11/17/2011	CA2799091A1 Novel cationic lipids and methods of use thereof
11/17/2011	CA2798856A1 Immunostimulatory and vaccine compositions
11/17/2011	CA2798401A1 Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
11/16/2011	EP2386646A1 Gene delivery system and methods of use
11/16/2011	EP2386640A2 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
11/16/2011	EP2386637A2 MicroRNA molecules
11/16/2011	EP2386636A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386312A2 Intrathecal and intratumoral superantigens to treat malignant disease
11/16/2011	EP2049154B1 Plasmid with immunological action
11/16/2011	EP1901768B1 Methods of modulating il-23 activity; related reagents
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	CN1789416B Human artificial chromosome containing human antibody lambda light chain
11/16/2011	CN102245773A Antibodies that specifically block the biological activity of a tumor antigen
11/16/2011	CN102245772A Short hairpin rnas for inhibition of gene expression
11/16/2011	CN102245766A Construction of protein-responsive shRNA/RNAi regulation system utilizing RNP motif
11/16/2011	CN102245629A Modified amyloid beta peptide
11/16/2011	CN102245215A Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
11/16/2011	CN102242150A Heat shock protein-GP96 (HSP-GP96) recombinant adenovirus vector and construction method and application thereof
11/16/2011	CN102242148A Recombinant vector, fibroin film modified by transgenic marrow stromal cells and application thereof
11/16/2011	CN102242131A Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof
11/16/2011	CN102242122A Nucleic acid aptamer specifically combined with HCV (hepatitis C virus) non-structural protein NS2, and application thereof
11/16/2011	CN102242117A Aquaporin 4-siRNA interfering sequence, its fusion expression vectors and medicinal use of the fusion expression vectors
11/16/2011	CN102242116A Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same
11/16/2011	CN102242080A Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24)
11/16/2011	CN102241790A Amphipathic chitosan derivative and preparation method and application thereof
11/16/2011	CN102241777A Targeted PTEN gene composite, and preparation method and application thereof
11/16/2011	CN102241774A Recombinant IgE-Fc-anti EGFR single chain variable fragment fusion protein, its preparation method and its application
11/16/2011	CN102240406A Method for realizing surface modification of tumor targeted nonviral vector and application thereof
11/16/2011	CN102240405A Apolipoprotein A-I (ApoA-I) milano genetic medicine
11/16/2011	CN102240404A Vibrio harveyi DNA vaccine and its construction method and application
11/16/2011	CN102240402A Method for preparing chicken genetic engineering immunopotentiator by akirin2 gene sequence
11/16/2011	CN102240267A Folate-receptor-mediated pH-sensitive Decoy-ODN (Decoy-oligodeoxynucleotide) nanoparticle preparation and preparation method thereof
11/16/2011	CN101914536B Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof
11/16/2011	CN101812452B Application of small interfering RNA (Ribonucleic Acid) of RALA (v-ral simian leukemia viral oncogene homolog A) gene in preparing medicaments for resisting leukemia
11/16/2011	CN101775410B Fowlpox virus vector shuttle plasmid and application thereof
11/16/2011	CN101395168B Galactose derivative,Drug carrier and medicinal composition
11/16/2011	CN101189343B Multiple rna polymerase iii promoter expression constructs
11/16/2011	CN101103112B Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
11/15/2011	US8058256 Polymeric carrier for delivery of small interfering RNA
11/15/2011	US8058254 DNA vaccines encoding heat shock proteins

1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 870